72 results for "Spike" in 产品
Spike Products
The Coronavirus Spike protein (S Protein) is one of four major structural proteins (S, M, E, N) present in each viral particle. Spike proteins are abundantly expressed on the surface forming its characteristic crown-like halo structure. The Spike protein is a highly glycosylated, type I transmembrane protein that plays a critical role in receptor r...
Ectodomain, Stabilized Prefusion Conformation, Resistant to Furin Cleavage
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
Omicron variant
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
Delta Variant (India) His-tag
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
GCN4-IZ trimerization domain, Stabilized Prefusion Conformation, Resistant to Furin Cleavage
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
(1-1273 4x aa mut.)
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
| Reactivity: | SARS-CoV |
| Source: | HEK293 |
| Accession #: | P59594.1 |
| Applications: | Bioactivity |
Beta Variant (South Africa)
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
Gamma Variant (Brazil)
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
Alpha Variant (UK)
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
L452R T478K Delta Variant (India)
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
Omicron Variant His-tag
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
Alpha Variant (UK) Resistant to Furin & Stabilized Prefusion Conformation
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
His-tag Kappa Variant (India)
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
Omnicron Variant
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
CHO Expressed, 4 Point Mutations
| Reactivity: | SARS-CoV-2 |
| Source: | CHO |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
5 Point Mutations (D614G, R682S, R685S, K986P, V987P)
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
CHO Expressed His-tag. Mutations: D614G, R682S, R685S, K986P, V987P
| Reactivity: | SARS-CoV-2 |
| Source: | CHO |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
| Reactivity: | BatCoV RaTG13 |
| Source: | CHO |
| Accession #: | QHR63300.2 |
| Applications: | Bioactivity |
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
D614G, Q677H
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
Beta Variant (South Africa)
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
Alpha Variant (UK) with E484K Point Mutation. His-tag.
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
Alpha Variant (UK) with S494P Mutation. His-tag
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
